DeepWork Portfolio Careers

Vycellix

vycellix.com

Vycellix, Inc. is an immunotherapy-focused discovery company dedicated to developing innovative allogeneic cell-based therapies that minimize immune rejection. Their proprietary platforms, including VY-UC and VY-GAGE, aim to enhance cell and gene therapies, particularly in the treatment of cancers. With a strong emphasis on natural killer (NK) cell therapeutics, Vycellix is positioned to address significant challenges in the field, offering simplified and effective solutions that could transform patient outcomes. The company is headquartered near the Moffitt Cancer Center in Tampa, Florida, and is actively engaged in advancing its research and development initiatives.